WebNov 10, 2024 · Christina Coughlin pictured above. (Photo courtesy of CytoImmune Therapeutics) CytoImmune Therapeutics is under new management. Cell therapy … WebDec 23, 2024 · CAMBRIDGE, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is …
Rubius Therapeutics Appoints Christina Coughlin, M.D., Ph.D., as …
WebMar 22, 2024 · Christina Coughlin. @coughlin582. Excited to join the Board . @avacta. The Affimer and preCISION platforms hold great promise for patients and are potentially disruptive in the oncology field. Looking forward to working with new and old colleagues @EliotForster. #AlastairSmith. Quote Tweet. WebGet Christina Coughlin's email address (c*****@gmail.com) and phone number (757-478-....) at RocketReach. Get 5 free searches. Rocketreach finds email, phone & social media for 450M+ professionals. Try for free at rocketreach.co reforming business and government pre-test
Christina Coughlin email address & phone number NYS …
WebFeb 3, 2024 · Christina Coughlin RUBY stock SEC Form 4 insiders trading. Christina has made over 1 trades of the Rubius Therapeutics Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently he bought 19,000 units of RUBY stock worth $104,880 on 22 April 2024.. The largest trade he's ever made was buying 19,000 units of Rubius … WebNov 10, 2024 · LOS ANGELES, Nov. 10, 2024 (GLOBE NEWSWIRE) -- CytoImmune Therapeutics, a privately-held cell therapy company focused on developing natural killer (NK) immune cells to fight cancer, announces the... reforming bureaucracy